John A. Rowley Ph.d.
Co-Founder and Chief Executive and Technology Offi
Cell Processing Technologies
ROOSTER BIO
United States of America
Biography
Dr. Jon A. Rowley, Ph.D. co-founded RoosterBio, Inc. in 2012 and serves as its Chief Executive and Technology Officer. Dr. Rowley serves as Innovation Director of Cell Processing Technologies at Lonza Biosciences. Dr. Rowley is responsible for driving technology development and innovation related to commercial scale bioprocessing of therapeutic cell-based products. He started his industry career at BD as a scientist and R&D manager in a Cell & Tissue Technologies group focused on applying high throughput screening technologies to cell therapy media development and tissue engineering. He then contributed to the clinical development of Aastrom Biosciences’ Tissue Repair Cell product, where he served as Senior Manager of Process Development responsible for manufacturing process improvements and cell delivery to the patient. He serves as Member of Advisory Board of BioCision, LLC. He spent 5 years as Director of Innovation and Process Development in Lonza’s Cell Therapy CMO business. Dr. Rowley has been Member of Scientific Advisory Board at BioLife Solutions, Inc. since January 2012. He has authored over 30 peer reviewed manuscripts and 15 issued or pending patents related to biomaterials development, tissue engineering, and cellular therapy. Dr. Rowley holds a PhD from the University of Michigan in Biomedical Engineering.
Research Interest
Cell Processing Technologies, Biomedical Engineering.
